Ikhadi Lokuhlola I-Rapid SARS-CoV-2 Antigen

Rapid 2019-nCoV IqG/IqM Combo Tost Cnrd ts nn •mmunoenromatOQraphy esekelwe isinyathelo esisodwa in vitro tost It « d<>siQfi©d for tho fuptd Qualitative delmmlnMion of IflG nr>d IflM antitxxJios to 20201RS novel coronavirus -2) phakathi somm yomuntu mmA. oc whole btood Rapid 2019-nCoV IgG/IgM Combo Tost Cnrd iwukutholwa kwe-supplomont ye-COVID-19 BKpoctod infectod patent bosidot nudoic nod tost engase ibambe ongezansi ukunemba kwe-cieloction (noma i-COVID19

ISIFINYEZO

Tho ”W coronnvirusos tx>lonq to tbo P genus COVID-19 H nn acute breathing infoctoous disease Poop«o om Oonocnlly suscoptiWo Njengamanje, iziguli ezingenwe inoveli i-coronavirus nomthombo oyinhloko we-mfoebon. n^ywplomatic mfoefod poog cah Futhi ube umthombo mfoebous kweyamanje ©p

ISIMISO

Ikhadi Lokuhlola I-Rnpxl 2019-nCoV Combo lisebenzisa i-pnnoplo ye-immuno^nromotoflrap^y. I-Mqum ant> -i-igM yomuntu kanye negundane miti igG yomuntu the umple well fottowed by IgG itnc Njengesampula encane ftown ngokusebenzisa i-membrane ngaphakathi kwedivayisi yokuhlola ye-IM i-recomt enemibala engu-2019-nCoV>nant 90M amafomu e-conjugate ahlanganisa amafomu athize

ama-nntibodios (IgM an

Ukungabikho kwebhendi ye-tg cokxed efasiteleni lokuhlola kubonisa umphumela wokuhlola othi ne^at/vo A bwn-

IZINTO EZINIKEZELWA

1 Ikhadi Lokuhlola I-Raprt 2019-nCoV IgG-lgM Combo

2 Isampula yebhafa

2 pL ipayipi le-capillary 4 Imiyalelo Yokusetshenziswa

IZINTO EZIDINGEKAYO KODWA AKUNIKEZWE

Iwashi noma isibali sikhathi, ama-lancets okuphepha, prep utshwala

ISITOREJI

Gcina idivayisi ye-tost ku-4 kuya ku-30°C esikhwameni se-soalod se-onflinnl Ungafaki Froozo.
Idethi yokuphelelwa yisikhathi uma>dicaie
Idivayisi hleze ihlale esikhwameni sama-fts esivaliwe ize ilungele ukusetshenziswa. Ngemuva kokuvula, idivayisi yokuhlola kufanele isetshenziswe ngokushesha. Ungayisebenzisi kabusha idivayisi.

IZINYATHELO ZOKUZIVIKELA

1 Okokusebenza kokuxilongwa kwe-in vitro kuphela

2 Umkhiqizo •$ stncUy for medical professional u$e only tod 曲 mwoded for personal use

3 Ungawusebenzisi umkhiqizo ngale kwedethi ye-exprsbon

4 Ungawusebenzisi umkhiqizo uma isikhwama, $ darnaged noma tM $«ai itxoken

5 Phatha zonke izifanekiso njengamandla athathelanayo

6 Landela inqubo ejwayelekile ye-Lat> aM tMOsafety fluxMhnet kanye nokulahlwa kwe-potemiaii/ okuthathelwanayo

impahla Lapho inqubo yokuhlola isiqediwe, lahla izibonelo ngemva kokuzifihla ku-121P kx okungenani imizuzu engu-20 Yokwelapha nge-0 5% Sodium HypochJonte f

UKUQOQWA KOMHLABA OKUNYE UKULUNGISWA

1 I-serum, i-plasma noma isampula yegazi lonke kufanele ibe yizimo ezijwayelekile ze-iatxxatory.

2 Ukushisa okungenayo i-KX) kwezibonelo, okungase kubangele i-hemolyse kanye nokukhishwa kwe-proton, kufanele kugwenywe.

3 Ukuhlolwa kusebenza kahle kakhulu kumasampula egazi/i-serum i plasma esanda kufakwa Uma ukuhlolwa kungenzeki ngokushesha, i-serum I plasma ingase igcinwe ku-2-8°C kuze kufike ezinsukwini ezi-3 uma kwenzeka (Ukuhlolwa ngendlela m Ukugcina isikhathi eside, ama-serum / plasma speamens angenziwa iqhwa ku-・20*C noma izinyanga ezi-3 noma ・70°C tef ipenodi ende Gwema ukufriza okuphindaphindiwe/thavwng imijikelezo.

I-4 Sodium az>de ingangezwa njengesivimbeli kuze kufike ku-0.1% ngaphandle kokuphazamisa imiphumela yokuhlolwa